JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR
Clinical trial NCT07510841 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07510841
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-30
- Primary completion
- 2029-05-31
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.